BodyNovaWellness
enes

← All peptides

Tirzepatide — Research use only
BodyNovaWellness

Tirzepatide

40 MG
Research use only
Not for human consumption
STORE REFRIGERATED 2–8 °C (36–46 °F)
Fat Loss & Metabolic
Research use only

Tirzepatide

A dual GIP and GLP-1 receptor agonist studied in metabolic research.

$95 USD per vial

Also known as: Tirzepatide, Trizepatide, T1XZ, GIP/GLP-1 dual agonist

Ask about this on WhatsApp

Overview

Tirzepatide is described in the literature as a single synthetic peptide, modified with a fatty-diacid side chain, that acts as an agonist at two receptors: GIP and GLP-1. It is studied in metabolic-regulation, glucose-metabolism, energy-balance, and body-composition research, where its dual-receptor activity is compared with that of single-receptor agonists. Published findings come from laboratory models and from clinical studies, and how they carry over between models and settings is still being examined. It is offered here for research use only.

Research highlights

  • A synthetic peptide with a fatty-diacid side chain
  • Studied for its role at GIP and GLP-1 receptors
  • Investigated in models of glucose metabolism
  • Explored in models of energy balance and body composition
  • Compared with single-receptor agonists in metabolic research

Related peptides